13:50 EDT Legend Biotech up 10% after report claims company received takeover interest
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LEGN:
- Legend Biotech to Host Investor Conference Call on Second Quarter 2024 Results
- 3 Best Stocks to Buy Now, 7/4/2024, According to Top Analysts
- Legend Biotech’s CARVYKTI® Triumphs in Phase 3 Trial
- Legend Biotech’s carvykti improves overall survival in Phase 3 myeloma trial
- Legend Biotech initiated with a Buy at Truist